Articles - 4e1h mentioned but not cited (2)
- Crystal structure of a human prion protein fragment reveals a motif for oligomer formation. Apostol MI, Perry K, Surewicz WK. J Am Chem Soc 135 10202-10205 (2013)
- The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
Reviews citing this publication (9)
- Structural, morphological, and functional diversity of amyloid oligomers. Breydo L, Uversky VN. FEBS Lett 589 2640-2648 (2015)
- Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG, Nowick JS. Acc Chem Res 51 706-718 (2018)
- An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations. Nagel-Steger L, Owen MC, Strodel B. Chembiochem 17 657-676 (2016)
- Ion mobility-mass spectrometry and orthogonal gas-phase techniques to study amyloid formation and inhibition. Hoffmann W, von Helden G, Pagel K. Curr Opin Struct Biol 46 7-15 (2017)
- Exploring amyloid oligomers with peptide model systems. Samdin TD, Kreutzer AG, Nowick JS. Curr Opin Chem Biol 64 106-115 (2021)
- Toward the Atomic Structure of PrPSc. Rodriguez JA, Jiang L, Eisenberg DS. Cold Spring Harb Perspect Biol 9 a031336 (2017)
- Structural mechanisms of oligomer and amyloid fibril formation by the prion protein. Sengupta I, Udgaonkar JB. Chem Commun (Camb) 54 6230-6242 (2018)
- Neurodegenerative disorders: dysregulation of a carefully maintained balance? Swart C, Haylett W, Kinnear C, Johnson G, Bardien S, Loos B. Exp Gerontol 58 279-291 (2014)
- Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils. Muschol M, Hoyer W. Front Mol Biosci 10 1120416 (2023)